NCCR2010
Advancing Medical Research in Malaysia: the next stage
4th National Conference for Clinical Research 2010
Incorporating:
• 13th Scientifi c Meeting of the National Institutes of Health
• Vaccines And Biologics Summit ~ Together We Can Build A Healthier World
2 - 4 June 2010 | Th e Royale Chulan Kuala Lumpur, Malaysia
Key topics & symposia:
• Research Governance & Ethics
• Regulation of Clinical Research in Malaysia: Update
• Early Clinical Development / Phase 1 studies in Malaysia
• Biobanking & clinical research
• Stem Cell Research & Therapy
• Healthcare Reform
• Healthcare Quality
• Clinical Performance monitoring
• Patient safety in Clinical Research
• Patient registries in Malaysia
• Malaysian Healthcare statistics
• Science to Business / Bio-entrepreneurship
• Contract Research Outsourcing (CRO)
industry in Malaysia: Update
• Globalization of clinical research & Asia
• Asian Clinical Trial Network
(Hong Kong, Thailand, Korea, Japan & Singapore)
• Therapeutic product evaluation
(Device, TCM, Post-marketing surveillance)
• Homegrown Vaccines – Innovative strategy on R&D and
development
• Vaccine R&D and Commercialisation - a non-linear link
• Vaccines Go Halal for the Muslim Market
• Asia’s Role in the Future of the Vaccine Industry
• Public-private partnerships – Experiences and Lessons Learnt
TOPICS and SPEAKERs :
|
SPEAKER NAME |
ORGANISATION |
TOPIC |
|
PLENARY |
|
1 |
Dr Nora Dellepiane*
|
Vaccine Quality and Regulation Group,
Quality, Standards and Safety team,
WHO
|
Considerations for supporting local vaccine production
|
|
2 |
Speaker to be advised |
|
R&D towards commercialisation in vaccines and biologics
|
|
3 |
Selvaraja Seerangam
|
Director,
National Pharmaceutical Control Bureau (NPCB),
Ministry of Health (MOH)
Malaysia
|
Shaping a biopharmaceutical regulatory framework |
|
Symposium 1. Overview of the vaccine industry |
|
1 |
Dr Martin Friede |
Initiative for Vaccine Research
Product Research & Development
Immunisation, Vaccines and Biologics
WHO
|
Asia’s role in the vaccine industry |
|
2 |
Dr B. Venugopalan
|
Senior Public Health Specialist (Epidemiology)
Head Unit
State Vector Borne Disease Control Unit
Selangor State Health Dept
Malaysia
|
Govt immunisation strategy |
|
3 |
Datuk Dr Zulkifli Ismail |
Former President,
Malaysian Paediatric Association
|
Getting new vaccines into the national immunisation programmes
|
|
Symposium 2. Planning for self-reliance and self-sustainability |
|
4 |
Eng. Mohamed Ali Toure |
Senior S&T Expert
Science & Technology Office
Islamic Development Bank (IDB)
|
Achieving Self-Reliance in Vaccine Production in the Islamic World (SRVP)
|
|
5 |
Prof Nguyen Thu Van* |
Director,
Company for Vaccine and Biological No. 1,
National Institute of Hygiene and Epidemiology (VABIOTECH),
Vietnam
|
The road to vaccines self-reliance – experiences and lessons learnt |
|
6 |
Mr Khalil Ahmed |
Executive Director
Shantha Biotechnics
India
|
Building local capacity through public-private partnerships |
|
Symposium 3. Vaccine manufacturing – GMP facility design and operation |
|
7 |
Vincent Hingot |
Project & Site Director
GSK Biologicals
Singapore
|
Cell-culture process scale-up
|
|
8 |
Dr. Mahendra Suhardono, Pharm. |
Production Director
PT Bio Farma
Indonesia
|
Building local capability for vaccine manufacturing
|
|
9 |
E.K.Lee |
Bioprocessing Research Lab
Dept. of Chemical Engineering
Hanyang University
Republic of Korea
|
Innovative downstream processing |
|
Symposium 4. Vaccines R&D |
|
10 |
Prof Nguyen Thu Van* |
Director,
Company for Vaccine and Biological No. 1,
National Institute of Hygiene and Epidemiology (VABIOTECH),
Vietnam
|
R&D in developing affordable essential vaccines |
|
11 |
Steven Drew |
Group CEO
Bioven Group
Malaysia
|
Challenges in research on cancer vaccines
|
|
12 |
Dr. Yeup YOON
|
341 Mogam Biotechnology Research Institute
Po-jung Ri, Koosung-Myun, Yongin City, Kyunggi-do
Korea 449-910
yy@mogam.re.kr
|
Development in biologics for the prevention, diagnosis and treatment of diseases |
|
Symposium 5. Regulatory issues |
|
13 |
Dr. Nora Dellepiane
|
Scientist
Vaccine Quality and Regulation Group,
Quality, Standards and Safety team,
WHO
|
WHO vaccines pre-qualification scheme |
|
14 |
Puan Eisah bt A.Rahman |
Deputy Director
Pharmaceutical Services,
MOH Malaysia
|
Current and future regulatory challenges in pharmaceuticals
|
|
15 |
Speaker to be advised |
|
Patent issues in biogenerics |
|
SUPER SESSIONS |
|
Session |
Date/ Venue/ Time |
Summary |
|
1 |
Entrepreneur Discussion Forum |
To be advised |
Open to all attendees for a thought-provoking discussion. Experience an open forum for conversation and networking around an important topic.
|
|
2 |
Getting Vaccines and Biologics Halal-certified – comparison between various certification bodies
|
To be advised |
A forum for discussion on Halal certification issues |